Study: Sickle Cell Drug Reduces Death Risk

  • Playlist
  • Download
  • Embed
    <iframe src="" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

A drug commonly prescribed for patients with sickle cell anemia not only eases symptoms of the disease, but also reduces the risk of death by 40 percent, a new study published in the Journal of the American Medical Association says. But it is unclear if hydroxyurea is appropriate for children. Hear NPR's Vicky Que.



Please keep your community civil. All comments must follow the Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

NPR thanks our sponsors

Become an NPR sponsor

Support comes from